PAQR8 and breast carcinoma: Consistent with the above findings, PAQR8 gain in primary breast cancers in The Cancer Genome Atlas (TCGA) was associated with shorter time to recurrence among those patients who recurred across all subtypes (p = 0.039, HR = 2.1) (Fig. 1C).